Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer

被引：0
|
作者：
Brian M Nolen
Jeffrey R Marks
Shlomo Ta'san
Alex Rand
The Minh Luong
Yun Wang
Kimberly Blackwell
Anna E Lokshin
机构：
[1] University of Pittsburgh Cancer Institute,Department of Surgery
[2] Hillman Cancer Center,Department of Mathematical Sciences
[3] Duke University Medical Center,Department of Biostatistics, Graduate School of Public Health
[4] Carnegie Mellon University,Department of Radiation Oncology
[5] University of Pittsburgh,Department of Medicine
[6] Duke University Medical Center,Department of Medicine, School of Medicine
[7] Duke University Medical Center,Department of Pathology
[8] University of Pittsburgh,Department of Obstetrics and Gynecology RS
[9] University of Pittsburgh,undefined
[10] University of Pittsburgh,undefined
来源：
Breast Cancer Research | / 10卷
关键词：
Epidermal Growth Factor Receptor; Migration Inhibitory Factor; Median Fluorescence Intensity; Locally Advanced Breast Cancer; Clinical Partial Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
    Nolen, Brian M.
    Marks, Jeffrey R.
    Ta'san, Shlomo
    Rand, Alex
    Luong, The Minh
    Wang, Yun
    Blackwell, Kimberly
    Lokshin, Anna E.
    BREAST CANCER RESEARCH, 2008, 10 (03):
  • [2] Serum protein expression predicts neoadjuvant chemotherapy response in patients with locally advanced breast cancer
    Kim, Ji-Yeon
    Park, Kyunghee
    Jung, Hae Hyun
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Park, Yeon Hee
    CANCER RESEARCH, 2020, 80 (04)
  • [3] CD8+ Serum as a predictor of Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer
    Qodir, Nur
    Umar, Mulawan
    Darwin, Nopriansyah
    Theodorus
    Journal of Physics: Conference Series, 2019, 1246 (01):
  • [4] Biomarker panel (TheraPrint) analyzed as a predictor of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Beitsch, Peter D.
    Stork, Lisette
    De Snoo, Femke
    Peeters, Justine
    Whitworth, Pat W.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Assessment of biomarker expression in predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Chhieng, David C.
    Rodriguez-Burford, Cristina
    Meleth, Sreelatha
    Grizzle, William E.
    Ferguson, Susan M.
    BREAST JOURNAL, 2007, 13 (05): : 534 - 535
  • [6] Multiplex immunoassays analysis of plasma biomarker levels and response to neoadjuvant chemotherapy for locally advanced breast cancer
    Cho, J. H.
    Park, K.
    Lee, E.
    Kim, Y.
    Park, S.
    Yoon, S. E.
    Lee, K. K.
    Hur, J. Y.
    Lee, S. K.
    Lee, J. E.
    Kim, S. W.
    Nam, S. J.
    Yu, J.
    Kim, J-Y.
    Jung, H. H.
    Park, Y. H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Neoadjuvant chemotherapy in locally advanced breast cancer
    Singh, G
    Singh, DP
    Gupta, D
    Muralikrishna, BV
    JOURNAL OF SURGICAL ONCOLOGY, 1996, 61 (01) : 38 - 41
  • [8] Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Iqbal, Javeria
    Shafi, Alam Ara
    Alharthi, Bandar N.
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (11): : 845 - 848
  • [9] Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
    Specht, Jennifer
    Gralow, Julie R.
    SEMINARS IN RADIATION ONCOLOGY, 2009, 19 (04) : 222 - 228
  • [10] Neoadjuvant chemotherapy for locally advanced breast cancer
    Fomenko, Y.
    Sirota, V.
    Bitz, U.
    Zhumakaeva, S.
    Omarova, I.
    Kabildina, N.
    ANNALS OF ONCOLOGY, 2016, 27
12345